Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Daiichi Sankyo gets Japenese nod for Tarlige tablets to treat neuropathic pain

Ruchika Sharma31 March 2022 9:45 AM IST

Tokyo: Daiichi Sankyo Company, Limited has announced that the company has obtained approval in Japan to change the indication of the analgesic...

UK study to test Pfizer COVID drug Paxlovid in hospitalised patients

Ruchika Sharma31 March 2022 9:45 AM IST

Recovery, led by the University of Oxford, will probe whether Paxlovid shortens the length of hospital stay or reduces the need for a mechanical...

Digital health firm Altibbi raises Rs 334 crore in series B round

Ruchika Sharma31 March 2022 9:30 AM IST

Dubai: Altibbi, a Middle East digital health platform founded in Jordan and headquartered in Dubai, has raised $44 million in a series B round to...

Strides: Dr R Ananthanarayanan to depart as MD, Arun Kumar to take charge

Ruchika Sharma30 March 2022 4:33 PM IST

Bengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has announced that Dr. R. Ananthanarayanan(Ananth) has decided to depart ...

Manufacturing of 35 APIs started in India under PLI scheme, says Govt

Ruchika Sharma30 March 2022 2:26 PM IST

Self manufacturing would lead to reduction in import dependence of the key raw materials used for producing medicines, Mandaviya added.

Govt fixes trade margins of over 40 costly cancer drugs

Ruchika Sharma30 March 2022 1:12 PM IST

The minister informed the House that the MRPs of these cancer medicines have been capped in such a manner that it cannot be more than 60 percent of...

Pfizer gets expanded USFDA emergency use nod for additional COVID Vaccine booster in adults aged 50 years and older

Ruchika Sharma30 March 2022 12:25 PM IST

The additional booster is to be administered at least four months after the first booster and is the same formulation and strength as prior...

Honour- Glasgow University research centre named after Biocon founders

Ruchika Sharma30 March 2022 11:42 AM IST

The USD 7.5 million donation was used to help fund the building of the Mazumdar-Shaw Advanced Research Centre and create a Professorial Chair, the...

Alembic Pharma buys 100 percent stake in Aleor Derma

Ruchika Sharma29 March 2022 2:56 PM IST

The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic.

Sanofi targets eczema-treatment product Dupixent peak sales of over 13 billion euros

Ruchika Sharma29 March 2022 1:21 PM IST

Paris: French healthcare group Sanofi, which lagged rivals in the race for COVID-19 vaccines, raised on Tuesday its peak sales target for...

Novo Nordisk gets USFDA nod for Ozempic 2 mg to treat type 2 diabetes

Ruchika Sharma29 March 2022 12:23 PM IST

Plainsboro: Novo Nordisk has recently announced that the US Food and Drug Administration (USFDA) has approved a 2 mg dose of Ozempic (semaglutide)...

Aurobindo Pharma acquires domestic formulation business of Veritaz for Rs 171 crore

Ruchika Sharma29 March 2022 11:47 AM IST

New Delhi: Drugmaker, Aurobindo Pharma, has recently announced the acquisition of domestic formulation business of Veritaz on a slump sale...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok